Sclnow Biotechnology Co., Ltd.   Report issue

For profit Phase 2
Founded: Beijing China (2012)

Organization Overview

First Clinical Trial
2017
NCT03180463
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Sclnow Biotechnology Co., Ltd.